VaLogic Bio
Providing GMP/GxP compliance and technology solutions since 2001.
Providing GMP/GxP compliance and technology solutions since 2001.
VaLogic Bio Analysis
VaLogic Bio has been providing GMP/GxP compliance and technology solutions since 2001. Specializing in Biotechnology, it offers a wide range of services including calibration, CQV, environmental monitoring, and certification, ensuring unwavering compliance, operational efficiency, and excellence. With a focus on pharmaceuticals, biotechnology, and life sciences, it has established itself as a reliable and trusted partner in GxP compliance.
Its specific scope of offerings includes design services for facilities and clean rooms, critical utilities, controlled temperature/humidity rooms, and risk-based validation. The company also provides building/implementing services such as integrated commissioning & qualification, equipment management & monitoring, and asset management systems like LogiCalTM and LogiPointTM. Additionally, it offers maintaining services like biorepository, environmental monitoring, and laboratory support services.
The company's last investment, a Private Equity Round, occurred on 29 November 2023 and was led by 424 Capital. Based in the United States, VaLogic Bio continues to be a key player in the GMP/GxP compliance industry, providing comprehensive solutions for its clients.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 | 424 Capital | 29 Nov 2023 |
No recent news or press coverage available for VaLogic Bio.
We care about your data, and we'd love to use cookies make your experience better.
